INTANGIBLE ASSETS (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets
Accumulated Amortization	$ (234,513)	$ (200,626)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	2,974,199	2,606,598
Net Amount	2,739,686	2,405,972
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,444,581	1,203,987
Net Amount	1,444,581	1,203,987
Multiple Trademarks [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	198,657	185,465
Net Amount	198,657	185,465
Opera Software Patent [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951	31,951
Accumulated Amortization	(7,488)	(6,490)
Net Amount	$ 24,463	$ 25,461
Weighted average remaining amortization period	12 years 3 months	12 years 9 months
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 91,743	$ 91,743
Accumulated Amortization	(91,743)	(91,743)
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,207,267	1,093,452
Accumulated Amortization	(135,282)	(102,393)
Net Amount	$ 1,071,985	$ 991,059
Weighted average remaining amortization period	15 years 6 months	16 years